Skip to main content
3SBio Inc. logo

3SBio Inc. — Investor Relations & Filings

Ticker · 1530 ISIN · KYG8875G1029 LEI · 529900P0TQC1E9Y7FN31 HKEX Manufacturing
Open in API
Filings indexed 1,491 across all filing types
Latest filing 2021-08-30 Interim / Quarterly Rep…
Country KY Cayman Islands
Listing HKEX 1530

About 3SBio Inc.

http://www.3sbio.com

3SBio Inc. is a biopharmaceutical enterprise specializing in the integrated research, development, production, and commercialization of innovative biopharmaceutical products. The company operates as a biotechnology firm, focusing on the discovery, development, manufacture, and marketing of biologics, with a particular emphasis on mammalian cell-based biopharmaceuticals. 3SBio addresses critical medical needs by providing an extensive range of products and services to markets both domestically and internationally.

Recent filings

Filing Released Lang Actions
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2021
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2021' and contains detailed unaudited consolidated financial statements including profit or loss, comprehensive income, financial position, segment information, and notes. It explicitly states it is an interim report prepared under HKAS 34 Interim Financial Reporting. The document length is substantial (15,000 characters) and contains actual financial data and analysis for a six-month period, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2021
2021-08-30 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for 3SBio Inc. It includes detailed information about repurchase of shares, dates, prices, and confirmations related to compliance with listing rules on the Stock Exchange of Hong Kong. The content focuses on share repurchase activity and capital changes rather than financial results, management changes, or regulatory certifications. The document length is 9882 characters, which is substantial and contains detailed transactional data. This matches the definition of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares.
2021-08-30 English
VOLUNTARY ANNOUNCEMENT - Phase III clinical trial of 5% Minoxidil Foam reaching the preset end point
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by 3SBio Inc. regarding the Phase III clinical trial results of 5% Minoxidil Foam reaching the preset end point. It is a press release providing detailed information about the clinical trial results, the significance of the findings, and future plans for drug application submission. The document is not a financial report, earnings release, or regulatory filing. It is a corporate announcement about clinical trial progress and results, which does not fit into financial or governance report categories. It is not a report publication announcement since it contains substantive information rather than just announcing the availability of a report. The document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about clinical trial results and company plans, which do not fit into other specific categories.
2021-08-30 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for 3SBio Inc. It details repurchase of shares, including number of shares repurchased, prices, and confirmations that the repurchases comply with listing rules. The document is a regulatory disclosure about share repurchases and changes in capital, not a full financial report or earnings release. It is not an announcement of a report publication but a detailed regulatory filing about share capital changes and repurchases. This fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares.
2021-08-27 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by 3SBio Inc. It details repurchase of shares, including number of shares repurchased, prices paid, and confirmations that the repurchases comply with listing rules. The document is a regulatory disclosure about share repurchases and changes in capital, not a full financial report or earnings release. It is not an announcement of a report publication but a detailed regulatory filing about share capital changes and repurchases. This fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares.
2021-08-26 English
ANNOUNCEMENT - (1) GRANT OF SHARE OPTIONS&#x3b; AND (2) PROPOSED SHARE REPURCHASE
Transaction in Own Shares Classification · 95% confidence The document is an announcement from 3SBio Inc. regarding (1) the grant of share options and (2) a proposed share repurchase. It references the Listing Rules of the Hong Kong Stock Exchange and details the number of options granted, exercise price, and validity period. It also discusses the intention to exercise a previously granted repurchase mandate but states that no shares have been repurchased yet. The document is structured as a formal announcement rather than a detailed report containing financial statements or comprehensive analysis. It does not contain actual financial data or results but rather informs the market and shareholders about corporate actions related to share options and share repurchase plans. This fits the category of a Transaction in Own Shares (POS) because it relates to share repurchase activities and share option grants, which are corporate actions involving the company's own shares. The document length (5609 characters) and content confirm it is not a full financial report or earnings release but a specific corporate announcement about share transactions.
2021-08-25 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.